{
  "id": "EFO_0001378",
  "name": "multiple myeloma",
  "evidences": {
    "count": 13,
    "rows": [
      {
        "disease": {
          "id": "EFO_0001378",
          "name": "multiple myeloma"
        },
        "target": {
          "id": "ENSG00000149554",
          "approvedSymbol": "CHEK1"
        },
        "diseaseFromSource": null,
        "literature": [
          "21958871"
        ],
        "publicationYear": 2011,
        "datasourceId": "europepmc",
        "datatypeId": "literature",
        "score": 0.18,
        "resourceScore": 18,
        "textMiningSentences": [
          {
            "section": "abstract",
            "text": "Recently simvastatin has been found to result in the synergistic induction of apoptosis with 7-hydroxystaurosporine (UCN-01) (a Chk1 inhibitor) in myeloma cells."
          },
          {
            "section": "abstract",
            "text": "Therefore we hypothesized that Chk1 plays a role in the anti-myeloma effect of simvastatin."
          },
          {
            "section": "abstract",
            "text": "These results suggested that the Chk1-Cdc25A-cyclin A/CDk2 pathway was involved in simvastatin-induced S-phase cell cycle arrest and apoptosis in multiple myeloma cell lines."
          },
          {
            "section": "title",
            "text": "Involvement of Chk1-Cdc25A-cyclin A/CDK2 pathway in simvastatin induced S-phase cell cycle arrest and apoptosis in multiple myeloma cells."
          }
        ],
        "significantDriverMethods": null,
        "cohortId": null,
        "cohortShortName": null,
        "cohortDescription": null,
        "mutatedSamples": null
      }
    ]
  }
}